Cargando…

Preoperative serum CA125: a useful marker for surgical management of endometrial cancer

BACKGROUND: Surgery plays an important role in the management of endometrial cancer at all stages, particularly early clinical stage. There are still many unanswered questions regarding optimal surgical management of endometrial cancer, particularly regarding which patients should undergo lymphadene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Tao, Huang, Ling, Zhang, Shulan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438478/ https://www.ncbi.nlm.nih.gov/pubmed/25964114 http://dx.doi.org/10.1186/s12885-015-1260-7

Ejemplares similares

Identification and characterization of endometrial carcinoma with tumor markers HE4 and CA125 in serum and endometrial tissue samples
por: Cuesta-Guardiola, Tatiana, et al.
Publicado: (2021)

Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment
por: Kwon, Janice S.
Publicado: (2019)

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer
por: Lombaers, Marike S., et al.
Publicado: (2023)

What is the predictive value of preoperative CA 125 level on the survival rate of type 1 endometrial cancer?
por: YILMAZ BARAN, Şafak, et al.
Publicado: (2021)

CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding
por: Nithin, Kumar U, et al.
Publicado: (2018)

Preoperative LMR and Serum CA125 Level as Risk Factors for Advanced Stage of Ovarian Cancer
por: Tang, Ying, et al.
Publicado: (2021)

Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion
por: Zhou, Xingchen, et al.
Publicado: (2017)

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study
por: Reijnen, Casper, et al.
Publicado: (2019)

Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes
por: Fang, Cheng, et al.
Publicado: (2017)

Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer
por: Povolotskaya, N., et al.
Publicado: (2014)

Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
por: Barr, Chloe E., et al.
Publicado: (2022)

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015)

CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting
por: Shawn LyBarger, K., et al.
Publicado: (2022)

Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients
por: Li, Xuan, et al.
Publicado: (2019)

Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma
por: Hu, Hai-Jie, et al.
Publicado: (2016)

Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
por: Fang, Tianyi, et al.
Publicado: (2019)

Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma
por: Qin, Lin
Publicado: (2023)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma
por: Huang, Yao, et al.
Publicado: (2020)

Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer
por: Tang, Ying, et al.
Publicado: (2020)

Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: The Asian experience 2000 to 2012
por: Patsner, Bruce, et al.
Publicado: (2013)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden
por: Liu, Liang, et al.
Publicado: (2016)

CA-125 is not a useful marker in metastatic breast cancer.
por: Seckl, M. J., et al.
Publicado: (1992)

Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma
por: Quan, Quan, et al.
Publicado: (2021)

Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer
por: Abdalla, Nabil, et al.
Publicado: (2016)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer
por: He, Shu-Ming, et al.
Publicado: (2011)

Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models
por: Yang, Bingyi, et al.
Publicado: (2016)

Prognostic significance of serum CA125 in the overall management for patients with gastrointestinal stromal tumors
por: Sui, Chao, et al.
Publicado: (2023)

Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery †
por: Lou, Yaochen, et al.
Publicado: (2021)

Oncological markers CA-125, CA 19-9 and endometriosis
por: Fiala, Ludek, et al.
Publicado: (2018)

Preoperative Serum CA-125 Level As a Predictor for The Extent of Cytoreduction in Patients with Advanced Stage Epithelial Ovarian Cancer
por: Merlo, Sebastjan, et al.
Publicado: (2021)

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
por: Gong, Sainan, et al.
Publicado: (2023)

Serum CA125 a potential marker of volume status for peritoneal dialysis patients?
por: Wijayaratne, Dilushi, et al.
Publicado: (2021)

Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma
por: Huang, Genping, et al.
Publicado: (2020)

Analysis of serum level of HE4 and CA125 considering selected risk factors among patients with endometrioid endometrial cancer
por: Abdalla, Nabil, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uc09sa9h8ntjdqoueocmsr47k6